2) were prescribed antidepressant medication by a provider after their first consultation on the Hims platform
B12 may enhance overall treatment adherence B12 can enhance treatment adherence while on tirzepatide therapy
Real-world data from a 2025 study in Diabetes, Obesity and Metabolism which looked at actual clinical patients rather than trial participants showed tirzepatide patients lost 5.3% of body weight over six months compared to 2.7% with semaglutide
Endometriosis itself does not directly cause weight gain, but many women experience weight changes due to treatment or lifestyle limitations caused by chronic pain
Svane MS, Jrgensen NB, Bojsen-Mller KN, Dirksen C, Nielsen S, Kristiansen VB, et al
Twenty-six percent of patients had been titrated to goal by the primary endpoint at Week 30, at which time the mean daily insulin dose was 29 units per day